nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Case of New-Onset Lichen Planus after COVID-19 Vaccination
|
Picone, Vincenzo |
|
|
12 |
3 |
p. 801-805 |
artikel |
2 |
An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study
|
Vendrely, Véronique |
|
|
12 |
3 |
p. 683-699 |
artikel |
3 |
A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17
|
Armstrong, April W. |
|
|
12 |
3 |
p. 787-800 |
artikel |
4 |
A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab
|
Blauvelt, Andrew |
|
|
12 |
3 |
p. 701-714 |
artikel |
5 |
Atopic Dermatitis and Psoriasis are Diagnosed Clinically and Treated Empirically
|
Aggarwal, Pushkar |
|
|
12 |
3 |
p. 611-614 |
artikel |
6 |
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago
|
Elberdín, Laida |
|
|
12 |
3 |
p. 761-770 |
artikel |
7 |
Characteristics of New Biologic Users Among the Moderate-to-Severe Psoriasis Population—Retrospective Cohort Study Leveraging the Modernizing Medicine Data Services Database
|
Fitzgerald, Timothy |
|
|
12 |
3 |
p. 741-752 |
artikel |
8 |
Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma
|
Morita, Akimichi |
|
|
12 |
3 |
p. 615-629 |
artikel |
9 |
Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis
|
Blauvelt, Andrew |
|
|
12 |
3 |
p. 727-740 |
artikel |
10 |
Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriasis
|
Gondo, George |
|
|
12 |
3 |
p. 753-760 |
artikel |
11 |
Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic
|
Esposito, Maria |
|
|
12 |
3 |
p. 671-681 |
artikel |
12 |
Effectiveness of Cimetidine as Adjuvant Therapy in the Treatment of Acute-Extrinsic Atopic Dermatitis: A Double-Blind Randomized Controlled Trial
|
Novianto, Endi |
|
|
12 |
3 |
p. 715-726 |
artikel |
13 |
Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents
|
Sidbury, Robert |
|
|
12 |
3 |
p. 631-642 |
artikel |
14 |
Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides
|
Alexander-Savino, Carolina V. |
|
|
12 |
3 |
p. 643-654 |
artikel |
15 |
Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study
|
Alexis, Andrew |
|
|
12 |
3 |
p. 771-785 |
artikel |
16 |
Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis
|
Wang, Xinyu |
|
|
12 |
3 |
p. 655-670 |
artikel |